Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sezin, Aşik Akman"'
Allergen variability and house dust mite sensitivity in pre-school children with allergic complaints
Autor:
Melike Kurtuluş-Çokboz, Soner Güneş, Selçuk Yazıcı, Gülce Baranlı, Sezin Aşik-Akman, Demet Can, Özlem Kemer
Yazici S, Gunes S, Kurtulus-Cokboz M, Kemer O, Baranli G, Asik-Akman S, Can D. Allergen variability and house dust mite sensitivity in pre-school children with allergic complaints. Turk J Pediatr 2018; 60: 41-49. The increase in the prevalence of all
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7430dc18e9222f403a77ac783f861cf1
https://hdl.handle.net/20.500.12462/6235
https://hdl.handle.net/20.500.12462/6235
Autor:
Oya, Haicioğlu, Sezin, Aşik-Akman, Işin, Yaprak, Görkem, Astarcioğlu, Tuna, Imamoğlu, Ali, Reisoğlu
Publikováno v:
The Turkish journal of pediatrics. 51(3)
Periosteal reaction has different etiologies in early infancy. Physiological periostitis is a well-documented X-ray finding seen in both preterm and term babies aged between 1-6 months and can easily be misdiagnosed as child abuse or pathological per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc8674051b6655185711e378d5f53b9b
https://pubmed.ncbi.nlm.nih.gov/20402081
https://pubmed.ncbi.nlm.nih.gov/20402081
Publikováno v:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 17(2)
Infliximab is a monoclonal antibody that targets TNF-alpha and has been shown to be effective for the management of steroid-dependent or refractory Crohn's disease. It is an effective therapy in adult patients, but experience in children is limited.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72dc52b0bdbc89e7506292b8c6b61968
https://pubmed.ncbi.nlm.nih.gov/16830299
https://pubmed.ncbi.nlm.nih.gov/16830299
Autor:
Sezin, Aşik Akman, Sabriye, Cokçeken Okçu, Oya Halicioiğlu Murat, Anil, Sükran, Köse, Ali Rahmi, Bakiler
Publikováno v:
Mikrobiyoloji bulteni. 40(1-2)
The combination therapy regimen of interferon (IFN)-alpha and lamivudine (LAM), a nucleoside analogue, is lately in use in chronic hepatitis B (CHB) infections. The aim of this study was the evaluation of the efficacy of IFN-alpha 2a and LAM combinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9b7e1d8e08d3f3d7803894dc5a0de35a
https://pubmed.ncbi.nlm.nih.gov/16775956
https://pubmed.ncbi.nlm.nih.gov/16775956